Nancy Chang

Nancy Chang

Directeur/Membre du Conseil chez IMMIX BIOPHARMA, INC.

Fortune : 8 M $ au 31/07/2026

76 ans
Health Technology
Commercial Services
Finance

Profil

Nancy T.
Chang
was the founder of Tanox, Inc., founded in 1986, where the titles held included Chairman, President & Chief Executive Officer from 1986 to 2006.
Current jobs include Chairman & Chief Executive Officer at Ansun Biopharma, Inc.; Independent Director at W&T Offshore, Inc. since 2023; Director at Iterion Therapeutics, Inc.; Director at ODC Therapy, Inc. since 2006; President & Director at Apex Enterprises, Inc. since 2007; Director at Inspirna, Inc.; Director at Avirmax, Inc.; Director at Immix Biopharma, Inc. starting 2025; President at 4j Therapeutics, Inc.; and President at Tang Family Foundation since 2009.
Former jobs include Chairman & Senior Managing Director at OrbiMed Advisors Private Equity from 2008 to 2012; Research Director at Centocor, Inc. from 1981 to 1986; Independent Director at SciClone Pharmaceuticals LLC from 2013 to 2017; Director at Charles River Laboratories International, Inc. from 2007 to 2011; Director at Federal Reserve Bank of Dallas from 2008 to 2009; Director at Apex Bioventures Acquisition Corp.
from 2006 to 2009; Director at Kun Run Biotechnology, Inc. in 2010; Independent Director at Helix Acquisition Corp.
from 2020 to 2022; Independent Director at Galera Therapeutics, Inc. (US) from 2024 to 2026; Associate Professor at Baylor College of Medicine from 1986 to 1991; and various directorships at Biotechnology Innovation Organization, Crown Bioscience, Inc., Applied Optoelectronics, Inc., Greater Houston Partnership Inc, Project HOPE-The-People-To-People Health Foundation, Inc., BioHouston, Inc., PharmAbcine Inc., and Eddingpharm (Cayman), Inc. Advisory roles include Advisory Board Member at Emerging Technology Partners LLC and Venture Partner at PTV Sciences LP.
Education includes undergraduate studies at Brown University and National Tsing-Hua University, and a doctorate from Harvard Medical School conferred in 1979.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
22/05/2026 918 880 ( 1,29 % ) 8 M $ 31/07/2026
15/07/2026 156 100 ( 0,1 % ) 560 399 $ 31/07/2026

Postes actifs de Nancy Chang

SociétésPosteDébut
IMMIX BIOPHARMA, INC. Directeur/Membre du Conseil 08/09/2025
W&T OFFSHORE, INC. Directeur/Membre du Conseil 28/04/2023
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur Général -
President 01/01/2007
President 01/03/2009
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 13/06/2006
░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ -

Anciens postes connus de Nancy Chang

SociétésPosteFin
░░░░░░ ░ ░░░ ░░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░ ░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Nancy Chang

Formation de Nancy Chang

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

72

Relations au 1er degré

34

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées34

Health Technology

Health Technology

Commercial Services

Health Technology

Energy Minerals

Government

Finance

Commercial Services

Commercial Services

Electronic Technology

Health Technology

Health Technology

Consumer Services

Health Services

Finance

Finance

Consumer Services

Consumer Services

Miscellaneous

Health Services

Commercial Services

Finance

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Finance

Miscellaneous

Health Technology

  1. Bourse
  2. Insiders
  3. Nancy Chang
🔇